为治疗器械相关症状而取出Essure装置:扩展病例系列及随访调查
回顾性病例系列评估52名2012至2016年间行腹腔镜或宫腔镜Essure取出术女性的围手术期结局及症状缓解情况,并对患者进行随访调查。32名(61.5%)回应调查,其中75%(24/32)报告生活质量几乎完全或完全改善,但31.3%(10/32)报告取出后症状持续或加重。结论认为Essure取出术可能对多数有器械相关症状的女性有效,但应告知部分症状可能持续甚至加重。
要点
- Essure取出术平均手术时间65分钟(SD 33),平均出血量31 mL(SD 17),无围手术期并发症。
- 调查应答者中75%(24/32)报告生活质量几乎完全或完全改善,87.5%(28/32)在四个领域均报告一定程度改善。
- 31.3%(10/32)报告取出后症状持续或加重,应告知患者部分症状可能持续甚至加重。
核心结论
- Essure取出术可能对多数有器械相关症状的女性有效。
- 应告知患者部分症状可能在术后持续甚至加重。
研究设计与样本
- 回顾性病例系列及患者随访调查(加拿大任务组分类III级)。
- 研究地点为大型学术医疗中心。
- 纳入2012年至2016年间接受腹腔镜或宫腔镜Essure取出术的52名女性。
主要发现
- 52名女性中32名(61.5%)回应调查。
- 32名应答者中75%(24/32)报告生活质量几乎完全或完全改善,56.3%(18/32)报告性生活改善,53.1%(17/32)报告盆腔痛改善,65.6%(21/32)报告日常活动改善。
- 87.5%(28/32)的应答者在四个查询领域均报告某种程度改善。
- 31.3%(10/32)的应答者报告取出后症状持续或加重。
- 所有手术耗时约一小时(平均65分钟,SD 33分钟),出血量少(平均31 mL,SD 17),无围手术期并发症。
临床怎么用
- 作者认为Essure取出术可能对多数有器械相关症状的女性有效。
- 作者建议应告知患者部分症状可能在术后持续甚至加重。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate perioperative outcomes and symptom resolution in women undergoing removal of the Essure device for device-attributed symptoms. DESIGN: Retrospective case series and follow-up patient survey (Canadian Task Force classification III). SETTING: Large academic medical center. PATIENTS: Fifty-two women who underwent laparoscopic or hysteroscopic Essure removal between 2012 and 2016. INTERVENTIONS: Women underwent one of four procedures: laparoscopic hysterectomy (LH) and bilateral salpingectomy (BS), laparoscopic BS and cornuectomy, laparoscopic Essure removal and BS, or hysteroscopic Essure removal and laparoscopic BS. MEASUREMENTS AND MAIN RESULTS: Fifty-two women who underwent Essure removal were asked to complete a survey regarding symptom resolution and quality of life following the procedure. Thirty-two women (61.5%) responded to the survey. Seventy-five percent (24/32) reported almost total or total improvement in quality of life, 56.3% (18/32) for sex life, 53.1% (17/32) for pelvic pain, and 65.6% (21/32) for daily activities. The majority of women reported some degree of improvement in all four domains queried (87.5%, 28/32). When asked about their symptoms in general, 31.3% (10/32) of women reported ongoing or worse symptoms after Essure removal. All procedures took approximately one hour (mean 65 min, SD 33 min), were associated with minimal blood loss (mean 31 mL, SD 17), and had no perioperative complications. CONCLUSION: Essure removal is a procedure that may be effective for treating most women with symptoms attributed to the device. Patients should be counseled that some symptoms may persist or even worsen following surgery.
引用
- Clark NV, Rademaker D, Mushinski AA, et al. Essure Removal for the Treatment of Device-Attributed Symptoms: An Expanded Case Series and Follow-up Survey. J Minim Invasive Gynecol. 2017. PMID: 28599885. doi:10.1016/j.jmig.2017.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。